MannKind's inhaled insulin verdict delayed | Reuters

Links shared publicly online about this topic.

  • 622
    total visits

MannKind's inhaled insulin verdict delayed | Reuters

reuters.com

BOSTON (Reuters) - MannKind Corp said U.S. regulators need an additional four weeks to complete their review of its experimental diabetes treatment, lifting the hopes of some investors who

View full resource at reuters.com

Tags: Diabetes, Insulin

  • Share

Most Recently Shared on December 28, 2010 at 5:15 pm By:

ReutersLisaRx Lisa Richwine

MannKind's inhaled insulin verdict delayed http://tinyurl.com/232vv7b

1 year ago...

UPDATE 3-MannKind's inhaled insulin verdict delayed | Reuters

reuters.com — “* Says FDA will not be able to complete review by Dec. 29 * Says FDA requires about 4 more weeks to complete review * Shares rise as much as 11.5 percent (Adds analyst comment, updates share price)View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on December 29, 2010 at 2:55 pm By:

ReutersDChealth Susan Heavey Health Communicator

Looks like another 4 wks until #FDA rules on $MNKD inhaled insulin: http://link.reuters.com/vyv93r #diabetes

1 year ago...

MannKind’s inhaled insulin verdict delayed | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com — “MannKind’s inhaled insulin verdict delayed | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.comView full resource at keyvive.com

  • View Related
  • Share

Most Recently Shared on December 28, 2010 at 10:51 pm By:

keyvive Aimee Greenholtz ePatient

MannKind’s inhaled insulin verdict delayed: MannKind Corp said U.S. regulators need an… http://goo.gl/fb/3iDbq

1 year ago...

MannKind Corporation's Inhaled Insulin Verdict Delayed; FDA Needs 4 More Weeks for to Review; Stock Rises 8% As of 10:17AM EST - News, Search Jobs, Events

biospace.com — “MannKind Corporation's Inhaled Insulin Verdict Delayed; FDA Needs 4 More Weeks for to Review; Stock Rises 8% As of 10:17AM EST - News, Search Jobs, EventsView full resource at biospace.com

  • View Related
  • Share

Most Recently Shared on December 28, 2010 at 5:02 pm By:

FiercePharma FiercePharma Health Site

RT @Biotechnology: MannKind's Inhaled Insulin Verdict Delayed; FDA Needs 4 More Weeks for to Review; Stock Rises 8% ... http://bit.ly/hQVTlG

1 year ago...

Advertisement